Pleased to address the WCO Council 2026. #INCB is grateful to @WCO_OMD for the long-standing cooperation promoting the goals of the @UN drug control treaties. Looking forward to our continued collaboration through innovative programmes and tools. 🌐👮♂️ #Customs@sevil_atasoy
The 146th session of #INCB has drawn to a close. I thank fellow Board Members for their work to safeguard health & welfare by supporting Member States in implementing the drug control treaties
My thanks to the secretariat, conference service staff & interpreters
@sevil_atasoy
Honoured to have been re-elected as #INCB President. Congratulations to the newly-elected officers. Looking forward to continuing to support States in implementing the drug control treaties to safeguard health & welfare. @sevil_atasoy https://t.co/GX4ESHcy1Z
Together with fellow Board Members & our secretariat, I was delighted to participate in #CND69 & engage with Member States, international & regional organizations & NGOs. #INCB is committed to enhancing implementation of the treaties & safeguarding health https://t.co/BLP6SCIpbC
Honoured to welcome H.E. Ambassador Andranik Hovhannisyan @MFAofArmenia, Chair of the Commission on Narcotic Drugs, to #INCB’s 145th session. We discussed the upcoming #CND69 session & efforts to improve implementation of the drug control treaties to safeguard health & welfare.
Just published - #INCB 2025 Annual and Precursor Reports. The Annual Report examines the impact of 60 yrs of #InternationalCooperation in drug control. More here ➡ https://t.co/3TyKYgyfNr
Working together is making a difference & protecting people from the harms of drugs, says @INCB_President Prof. Sevil Atasoy. The #INCB 2025 Annual Report looks at the effectiveness of #InternationalCooperation in drug control over 60 yrs ⬇
People's health & wellbeing have been protected by #InternationalCooperation & the collective action of States through the framework of the drug control conventions, the International Narcotics Control Board Annual Report says. More photos here ➡ https://t.co/9s9OWzXdpN
Delighted to launch INCB's 2025 reports. The thematic chapter of the Annual Report shows the impact of #InternationalCooperation, including #INCB tools, in safeguarding people from the harms of drugs and ensuring #availability of controlled medicines. https://t.co/xmUInkEiqA
Delighted to deliver an online statement at the World Health Assembly #WHA78 side event “A New Horizon of Hope - Galvanizing global momentum to improve access and availability to essential medicines”. #INCB@WHO
Thanks to the NGOs for their insights on international cooperation in drug control, which will be considered in the preparation of the 2025 #INCB Annual Report. Thanks to @theVNGOC for identifying speakers and for facilitating our ongoing engagement with civil society.
Congratulations to Prof. Sevil Atasoy on her election as #INCB President. My thanks to the Board Members and secretariat for their trust and support, and to Member States & partners for their cooperation. It has been an honour to serve as #INCB President for the past two years.
Honoured to be elected as #INCB President, an office that I first held in 2009. I thank outgoing President @ProfToufiq for his leadership over the past two years. I look forward to working closely with Member States, partner organizations and NGOs to safeguard health & welfare.
Delighted to welcome H.E. Ambassador Kumaran, Chair of the Commission on Narcotic Drugs, to the 143rd session of #INCB@UN_Vienna as part of ongoing cooperation to safeguard health and welfare through implementation of the drug control treaties.
Pleased to continue cooperation with @UNHumanRights at #INCB’s 143rd session. Our discussion covered a range of issues, reflecting the cross cutting nature of #HumanRights and the need to ensure that all facets of drug control fully respect global human rights standards and norms
Pleased to welcome @WHO to #INCB's 143rd session. Topics discussed included the outcomes of the recent #WHA78, scheduling, access to controlled medicines, prevention of drug misuse, and treatment of drug use disorders, including opioid agonist therapy.